Baby Powder Pulled From Shelves Due to Cancer
Reports out of the nation of Qatar show that country is taking the threat of talcum powder cancer seriously following the outcome of the U.S. baby powder cancer lawsuit in 2016.
Tuesday, March 29, 2016 - Johnson's baby powder has been banned from stores in Qatar while the country examines the risk of talcum powder ovarian cancer, according to an article published in a Qatari newspaper, Al Raya. This announcement came after news reached the country of the prominent baby powder cancer lawsuit in the United States in early 2013.
The talcum powder lawsuit that sparked this major move in Qatar resulted in $72 million in combined damages awarded to the plaintiff, reinforcing allegations that Johnson's baby powder causes ovarian cancer. While the baby powder cancer lawsuit outcome does not serve as proof that talcum powder is carcinogenic to women, it strongly supports the notion. The jury in this Johnsons baby powder lawsuit examined talcum powder cancer research in great depth, in addition to considering numerous internal company documents showing company officials have long been aware of the talcum powder cancer link. The jury in the baby powder lawsuit found J&J guilty of conspiracy, fraud and negligence for failing to warn American consumers of the talcum powder ovarian cancer connection.
The ban of talcum powder products was issued by the Qatari Ministry of Municipality and the Environment on a temporary basis while the government agency examines evidence presented in the baby powder cancer lawsuit. A governmental committee was convened to examine the safety of baby powder and other talc-based body products, prior to the baby powder cancer lawsuit outcome.
Numerous grocery stores and drug stores carry Johnson & Johnson products. A J&J representative in Qatar insisted Johnson's baby powder and other talc products are safe for regular use, despite the findings of the American talcum powder lawsuit in February 2016:
As aligned with the (Qatari) authorities, additional testing is being performed to provide full reassurance regarding the product's safety. Consumers in Qatar can be confident that every Johnson's baby product meets the highest standards for safety.
No announcement has been made yet by the Qatari government on its findings on the subject of baby powder cancer. Until the government agency finishes its investigation, Qatar stores will not be permitted to sell Johnson's baby powder.
The American Talcum Powder Cancer Lawsuit
The baby powder lawsuit that has sent waves of alarm around the globe was brought forth by Jacqueline Fox, a woman who was diagnosed with ovarian cancer after several decades of using talcum powder and Johnson's baby powder for daily feminine hygiene. Ms. Fox passed away just months before her case was resolved, after a long battle with ovarian cancer. She stated she would not have used Johnson's baby powder or its other talc products if she had been warned about the potential risk for ovarian cancer. Ms. Fox died at the age of 62, leaving behind a son who represented her interests in the baby powder lawsuit in St. Louis.
Ms. Fox's son stated that his mother's primary goal was to exact some influence over Johnson & Johnson, hoping to bring the talcum powder cancer risk into the view of the American public. According to her son, monetary compensation was not his mother's main goal, but a staggering $72 million in damages was awarded to her family as compensation for her ovarian cancer.
In this baby powder lawsuit, the jury examined evidence that indicates J&J officials were aware of talcum powder cancer research in the 1980s and actively worked to counter its effects on product sales by funding a task force designed to protect talcum powder producers' interests. Internal company memos showed executives discussed the impact the talc cancer research would have on baby powder sales, and chose not to warn consumers. Dr. Daniel Cramer, who testified in the baby powder lawsuit, estimates that approximately 10,000 American woman contract ovarian cancer each year as a result of using talcum powder.
No-Cost, No-Obligation Baby Powder Cancer Lawsuit Case Review for Women and Families of Women Who Were Diagnosed with Ovarian Cancer and Have a History of Using Talcum Powder
The Onder Law Firm
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit Talcum Powder Cancer Lawsuit Center or call 1-877-ONDER-LAW.